Curis, Inc. Banner Image

Curis, Inc.

  • Ticker CRIS
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Curis, Inc. Logo Image
  • 51-200 Employees
  • Based in Lexington, Massachusetts
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers. The company develops CUDC-907, an oral small molecule inhibitor of histone deacetylase and phosphatidylinositol-3-kinase enzymes, which is in Phase I clinical trials for advanced lymphomas and multiple myeloma; and HER 2-/ ER+ or PR+ breast cancer, and NUTMore midline carcinoma.
4.8 / 5.0 (144)

Curis, Inc. reports have an aggregate usefulness score of 4.8 based on 144 reviews.

Curis, Inc.

Most Recent Annual Report

Curis, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Curis, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Curis, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!